Elevance Health Inc (ELV)

Elevance Health, Inc. is a U.S.-based health benefits company listed on the NYSE as common stock under the ticker ELV. Through its subsidiaries, the company operates across four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. Its business includes health plans and related services for individual, employer group, BlueCard, Medicare, Medicaid, and FEP members, along with administrative managed care services and specialty insurance products such as stop loss, dental, vision, and supplemental health coverage. Elevance Health also has pharmacy services operations that include home delivery and specialty pharmacies, claims processing, formulary management, rebate administration, and member support. In addition, the company provides a range of healthcare services, including care management, behavioral health, virtual care, payment integrity, clinical analytics, and other support capabilities. It markets its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. Formerly known as Anthem, Inc., the company adopted its current name in 2022 and is headquartered in Indianapolis, Indiana.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-ELV
$453.19
10.3% Upside
Fair
$451.38
9.8% Upside
Fair
Great
September 25, 2026
1.7%
October 21, 2026
18.1x
2.0x
0.4x
89.122 B
101.4 B
25.7%
99.8%
4.2
30.4%
126.7%
Valuation • Fair Value

Elevance Health Inc (NYSE-ELV) Fair Value by Valuation Model

Review the available estimates for Elevance Health Inc (NYSE-ELV), including Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$453.19

Estimated upside of 10.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$253.92

Classic Ben Graham valuation formula reference.

DDM Fair Value

$458.68

Dividend discount model valuation reference.

Comps Fair Value

$449.53

Comparable-company valuation reference.

Analyst Price Target

$451.38

Analysts imply upside of 9.8%.

How to read these valuation models

Use the 6 available valuation references for Elevance Health Inc (NYSE-ELV) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Elevance Health Inc (NYSE-ELV)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

201.1 B

Current operating scale indicator.

Revenue Forecast

196.4 B

Forward revenue estimate.

EBITDA

8.324 B

Current operating profitability reference.

EBITDA Forecast

10.543 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Elevance Health Inc (NYSE-ELV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Elevance Health Inc (NYSE-ELV)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.51

No elevated caution signal from this screen.

Altman Z-Score

4.2

Relatively strong balance-sheet zone.

FCF / Net Income

126.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Elevance Health Inc (NYSE-ELV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Elevance Health Inc (NYSE-ELV)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 21, 2026

Days to Earnings

33

Dividend Payment Date

September 25, 2026

Dividend Yield

1.7%

Current income yield reference.

Payout Ratio

30.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Elevance Health Inc (NYSE-ELV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Elevance Health Inc (NYSE-ELV) Stock Forecast & Technical Outlook

Review Elevance Health Inc (NYSE-ELV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Elevance Health Inc (NYSE-ELV) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Elevance Health Inc (NYSE-ELV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Elevance Health Inc (NYSE-ELV) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Elevance Health Inc (NYSE-ELV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Elevance Health Inc (NYSE-ELV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Elevance Health Inc (NYSE-ELV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Elevance Health Inc (NYSE-ELV) has a Buy consensus, with 12 buy, 8 hold and 0 sell recommendations in the current data set.

Buy 12
Hold 8
Sell 0
FAQ Fast Investor Answers

Elevance Health Inc (NYSE-ELV) Stock FAQ

Data-supported answers about Elevance Health Inc (NYSE-ELV), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$453.19
Estimated upside 10.3%
Valuation Rating
Undervalued
Estimated upside of 10.3%
Analyst Target
$451.38
Implied upside 9.8%
Financial Health
Great
Current financial-health read

The current fair value estimate for Elevance Health Inc (NYSE-ELV) is $453.19. This implies an estimated upside of 10.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 10.3% versus the current market price.

The available analyst price target for Elevance Health Inc (NYSE-ELV) is $451.38. The analyst target implies estimated upside of 9.8%.

The current financial health read for Elevance Health Inc (NYSE-ELV) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Elevance Health Inc (NYSE-ELV) is October 21, 2026.

Based on the current data, dividend yield is 1.7%, payment date is September 25, 2026.

The current P/E ratio listed for Elevance Health Inc (NYSE-ELV) is 18.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Elevance Health Inc is 89.122 B.

The current enterprise value listed for Elevance Health Inc is 101.4 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Elevance Health Inc is NYSE-ELV, and the stock is listed on NYSE.

Elevance Health Inc (NYSE-ELV) is listed on NYSE.

The current debt-to-total-capital ratio listed for Elevance Health Inc is 25.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Elevance Health Inc is 99.8%. Free float helps investors understand how much of the share base is available for public trading.